All posts by Scott Power
Senior Analyst
Sectors Covered: Healthcare, Life Sciences
By Scott Power
03 September 2021, 9:00 AM
Ebos Group (ASX:EBO) has added to its medical consumables portfolio, with the well flagged acquisition of a medical consumables business.
Read more...
By Scott Power
24 August 2021, 7:00 AM
Mach7 Technologies (ASX:M7T) posted an in-line result for FY21. The highlights included a record sales order book and further R&D spend (28% of revenue) into new product development.
Read more...
By Scott Power
19 August 2021, 12:00 PM
Ebos Group (ASX:EBO) posted a strong FY21 result in line with our forecasts, with the highest recorded ROCE (18.0%) reflected by double digit earnings growth.
Read more...
By Scott Power
18 August 2021, 1:00 PM
Ebos Group (ASX:EBO) posted a strong FY21 result in line with our forecasts, with the highest recorded ROCE (18.0%) reflected by double digit earnings growth.
Read more...
By Scott Power
10 August 2021, 9:30 AM
The Morgans Healthcare Team provides a preview of the upcoming reporting season, highlighting their key stock picks.
Read more...
By Scott Power
09 July 2021, 5:00 PM
Senior Analyst Scott Power, updates on stocks in the Healthcare sector.
Read more...
By Scott Power
01 July 2021, 4:00 PM
Nanosonics (ASX:NAN) has launched a new digital platform, AuditPro™ offering digital traceability, reporting and compliance providing a new revenue stream which we think has good potential.
Read more...
By Scott Power
15 April 2021, 8:00 AM
Morgans Senior Analyst Scott Power speaks with Chief Executive Officer of Control Bionics, Rob Wong, on the significant progress the healthcare company is making.
Read more...
By Scott Power
12 April 2021, 3:30 PM
Mach7 Technologies 3QFY21 result has restored investor confidence. Pleasingly, A$12.8m in new sales orders were generated for the quarter.
Read more...
By Scott Power
18 March 2021, 11:15 AM
Volpara has announced its largest contract to date worth over US$400,000. The next catalyst will be an increasing ARPU to be reported in the 4QFY21 cashflow report.
Read more...